PRIMARY OBJECTIVES:~I. Uptake of MammoScreen (the proportion of women who enroll and use MammoScreen, also referred to as Reach.~II. Identification of women with above-average risk for breast cancer by MammoScreen integrated with the electronic health record (EHR).~SECONDARY OUTCOMES:~I. Rates of mammography screening referral. II. Screening completed and mammography results stratified by risk category. III. Among those who meet criteria, genetic counseling referral, visit completed and genetic test done.~OUTLINE:~CLINICAL STAFF: During development some clinical team members will participate in usability testing (up to 30 minutes) of the electronic health record interface with MammoScreen. Some participants will participate in interviews lasting up to 30 minutes at baseline, then undergo training sessions of about 20 minutes monthly prior to MammoScreen launch. Clinical staff also participate in interviews up to 30 minutes after MammoScreen launch during years 2-4. Participants complete surveys during the first month of the maintenance phase.~PATIENTS: Patients participate in interviews lasting up to 1 hour. Patients medical records are reviewed. Patients will be invited via MyChart to use the MammoScreen. Reminders will be sent via MyChart to non-respondents at 2 and 4 weeks. Patients will use MammoScreen one time right after enrollment. Some patients may also participate in interviews up to 1 hour each during years 3-5.
This study collects information to implement MammoScreen for Breast Cancer Screening and Referrals. MammoScreen is a risk assessment questionnaire that identifies individuals at average and increased risk for breast cancer and guides their screening decisions.